Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raimondo Bruno

Showing results (101-110 of 267) with videos related to

Pageof 27
Sort By:
BMC Psychiatry|December 2, 2016
Study protocol: a dose-escalating, phase-2 study of oral lisdexamfetamine in adults with methamphetamine dependenceNadine Ezard, Adrian Dunlop, Brendan Clifford, et al.
Drug and Alcohol Dependence|February 25, 2021
Trends and characteristics of extra-medical use of quetiapine among people who regularly inject drugs in Australia, 2011-2018Rachel Sutherland, Rashmi Jayathilake, Amy Peacock, et al.
The Clinical Journal of Pain|July 29, 2015
Sleep Quality Among People Living With Chronic Noncancer Pain: Findings From the Pain and Opioids IN Treatment (POINT) CohortNicholas Lintzeris, Ranira Moodley, Gabrielle Campbell, et al.
Research in Social & Administrative Pharmacy : RSAP|April 30, 2017
A nationwide study of the extent and factors associated with fentanyl use in AustraliaNatasa Gisev, Briony Larance, Elena Cama, et al.
Cannabis and Cannabinoid Research|September 2, 2017
Preliminary Development of a Brief Cannabis Use Disorder Screening Tool: The Cannabis Use Disorder Identification Test Short-FormMarcel O Bonn-Miller, Adrienne J Heinz, Everett V Smith, et al.
Substance Use & Misuse|June 27, 2006
Alcohol use and risk taking among regular ecstasy usersCourtney Breen, Louisa Degenhardt, Stuart Kinner, et al.
Pharmacoepidemiology and Drug Safety|October 1, 2015
A typology of people who tamper with pharmaceutical opioids: responses to introduction of a tamper-resistant formulation of controlled-release oxycodoneAmy Peacock, Louisa Degenhardt, Briony Larance, et al.
Current Drug Safety|September 7, 2012
Effects of filtration on the presence of particulate and oxycodone content of injections prepared from crushed OxyContin® tabletsPankaj Patel, Rahul P Patel, Susan Brandon, et al.
International Journal of Clinical Pharmacy|June 14, 2020
What predicts pharmacists' engagement with opioid-outcome screening? Secondary analysis from an implementation study in community pharmacySuzanne Nielsen, Paul Sanfilippo, Louisa Picco, et al.
Drug and Alcohol Review|December 17, 2019
Correlates of indicators of potential extra-medical opioid use in people prescribed opioids for chronic non-cancer painThomas Santo, Briony Larance, Raimondo Bruno, et al.
Pageof 27

Showing results (101-110 of 267) with videos related to

Sort By:
Pageof 27
BMC Psychiatry|December 2, 2016
Study protocol: a dose-escalating, phase-2 study of oral lisdexamfetamine in adults with methamphetamine dependenceNadine Ezard, Adrian Dunlop, Brendan Clifford, et al.
Drug and Alcohol Dependence|February 25, 2021
Trends and characteristics of extra-medical use of quetiapine among people who regularly inject drugs in Australia, 2011-2018Rachel Sutherland, Rashmi Jayathilake, Amy Peacock, et al.
The Clinical Journal of Pain|July 29, 2015
Sleep Quality Among People Living With Chronic Noncancer Pain: Findings From the Pain and Opioids IN Treatment (POINT) CohortNicholas Lintzeris, Ranira Moodley, Gabrielle Campbell, et al.
Research in Social & Administrative Pharmacy : RSAP|April 30, 2017
A nationwide study of the extent and factors associated with fentanyl use in AustraliaNatasa Gisev, Briony Larance, Elena Cama, et al.
Cannabis and Cannabinoid Research|September 2, 2017
Preliminary Development of a Brief Cannabis Use Disorder Screening Tool: The Cannabis Use Disorder Identification Test Short-FormMarcel O Bonn-Miller, Adrienne J Heinz, Everett V Smith, et al.
Substance Use & Misuse|June 27, 2006
Alcohol use and risk taking among regular ecstasy usersCourtney Breen, Louisa Degenhardt, Stuart Kinner, et al.
Pharmacoepidemiology and Drug Safety|October 1, 2015
A typology of people who tamper with pharmaceutical opioids: responses to introduction of a tamper-resistant formulation of controlled-release oxycodoneAmy Peacock, Louisa Degenhardt, Briony Larance, et al.
Current Drug Safety|September 7, 2012
Effects of filtration on the presence of particulate and oxycodone content of injections prepared from crushed OxyContin® tabletsPankaj Patel, Rahul P Patel, Susan Brandon, et al.
International Journal of Clinical Pharmacy|June 14, 2020
What predicts pharmacists' engagement with opioid-outcome screening? Secondary analysis from an implementation study in community pharmacySuzanne Nielsen, Paul Sanfilippo, Louisa Picco, et al.
Drug and Alcohol Review|December 17, 2019
Correlates of indicators of potential extra-medical opioid use in people prescribed opioids for chronic non-cancer painThomas Santo, Briony Larance, Raimondo Bruno, et al.
Pageof 27